Log in
Enquire now
‌

DIMAGI, INC. SBIR Phase I Award, September 2023

A SBIR Phase I contract was awarded to Dimagi in September, 2023 for $274,878.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

OverviewStructured DataIssuesContributors

Contents

sbir.gov/node/2511163
Is a
SBIR/STTR Awards
SBIR/STTR Awards
0

SBIR/STTR Award attributes

SBIR/STTR Award Recipient
Dimagi
Dimagi
0
Government Agency
0
Government Branch
National Institutes of Health
National Institutes of Health
0
Award Type
SBIR0
Contract Number (US Government)
1R43AG084434-010
Award Phase
Phase I0
Award Amount (USD)
274,8780
Date Awarded
September 30, 2023
0
End Date
September 29, 2024
0
Abstract

PROJECT SUMMARY It has been shown that conversations on end-of-life care focused on a patient’s goals of care can reduce psychological distress and anxiety and lead to improved quality of life, and potentially prolonged life, for patients living with serious illness. The Serious Illness Conversation Guide (SICG) is a validated and widely used framework for training the critical communication skills needed to effectively conduct these conversations; however, there currently exists no mechanism to easily support and continue to build these skills in a scalable way. Evidence suggests that conversational agents, i.e., chatbots, can be used for training and reinforcing communication skills. In this Phase I SBIR project, we propose to optimize and assess the feasibility and acceptability of a chatbot designed to augment SICG training for healthcare professionals (HCPs) on initiating and conducting sensitive conversations with patients diagnosed with serious illness. We will develop and test a chatbot directly with HCPs who are navigating serious illness conversations and/or may be expected to in the future. We will demonstrate feasibility and acceptability of an enhanced chatbot prototype through the following two specific aims: In Aim 1, we will create and adapt chatbot content and build an enhanced, fully functional prototype of the chatbot with expert inputs. The chatbot will feature 3 different patient scenarios ranging in case complexity. In Aim 2, we will conduct a pilot usability study of the prototype with 50 target end users—a diverse sample of HCPs varying in role, specialty, and career phase who have received at least one training session in the SICG. Following enrollment, HCPs will independently test the chatbot-led training and complete surveys at 3 timepoints—baseline, endline, and 1-month after enrollment—to assess the following outcome measures: pre-/post-training confidence in having serious illness conversations, usability, and user satisfaction. Semi-structured endline interviews will be conducted with a purposive sample of 15-20 HCPs to collect additional qualitative feedback on user experience and recommendations for improvement. Results of this Phase I SBIR project will inform a larger scale implementation study in potential Phase II work to evaluate the effectiveness and cost-effectiveness of the proposed intervention to reinforce and augment critical communication skills essential to the care of seriously ill patients.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like DIMAGI, INC. SBIR Phase I Award, September 2023

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.